Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PerioPatch is a topically applied, mucoadhesive herbal patch designed to treat localized oral inflammatory conditions such as gingivitis and periodontitis. Developed by Izun Pharma, the patch contains a proprietary blend of herbal extracts—including *Centella asiatica*, *Echinacea purpurea*, and *Sambucus nigra*—that act to reduce inflammation and promote tissue healing. It works by forming a physical barrier over the affected area while releasing active ingredients that inhibit inflammatory enzymes like beta-glucuronidase and matrix metalloproteinases (MMPs). The patch is designed to adhere to the oral mucosa, providing sustained delivery of its botanical components directly to the site of inflammation to reduce symptoms such as bleeding and swelling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PerioPatch (Izun Pharmaceuticals).